tenofovir has been researched along with Lymphoma, B-Cell, Marginal Zone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huits, RM; Koot, AW; Visscher, AP | 1 |
| Gómez Espín, R; Muñoz Bertrán, E; Ortega González, I; Pérez Ceballos, E | 1 |
1 review(s) available for tenofovir and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
[Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab].
Topics: Adenine; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Specificity; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Fatal Outcome; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunologic Factors; Immunotherapy; Liver Failure; Lymphoma, B-Cell, Marginal Zone; Male; Organophosphonates; Prednisone; Recurrence; Rituximab; Tenofovir; Vincristine; Virus Activation | 2010 |
1 other study(ies) available for tenofovir and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
Remission of splenic marginal zone lymphoma in a patient treated for hepatitis B: a case of HBV-associated lymphoma.
Topics: Adenine; Bone Marrow; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunohistochemistry; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Organophosphonates; Remission Induction; Splenic Neoplasms; Tenofovir; Viral Load | 2015 |